Xarelto panel real-time update: Based on JNJ’s presentation so far, I think the liver-toxicity (“ghost of Exanta”) issue will turn out to be a non-issue. JNJ’s presenter just showed some compelling graphs relating to Hy’s Law.
There has not yet been any discussion of Xarelto’s bleeding risk.
Market Data 
Markets 
AI
